This was a Phase I , single-centre , randomised , double-blind , three-way crossover study during which subjects received three single doses of @ g rectal suppositories ( containing @ or @ mg NRL@ or matching placebo ) or @ g rectal suppositories ( containing @ or @ mg NRL@ or matching placebo ) on three separate dosing days .